Neurodevelopment in children infected andor affected by HIVAIDS in subSaharan Africa' PowerPoint PPT Presentation

presentation player overlay
1 / 41
About This Presentation
Transcript and Presenter's Notes

Title: Neurodevelopment in children infected andor affected by HIVAIDS in subSaharan Africa'


1
Neurodevelopment in children infected and/or
affected by HIV/AIDS in sub-Saharan Africa.
  • Annelies Van Rie, Aimee Mupuala, Anna Dow, Nadine
    Nosse, Iam Zephyrin
  • Work funded by NIH/NIMH
  • BRAIN DISORDERS IN THE DEVELOPING WORLD RESEARCH
    ACROSS THE LIFESPAN

2
Twin girls, age 8 months
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
HIV infection and CNS in children
  • Neurological manifestations of HIV infection in
    vertically infected children impairs the
    development and growth of an immature CNS
  • CNS involvement presents as static or progressive
    HIV encephalopathy (PHE), with microcephaly,
    delay or loss of developmental milestones (motor,
    mental and language), and pyramidal tract
    symptoms (Belman 1988)
  • Prevalence in pre-HAART era in the USA 30 to 50
    (Epstein 1986, Sharer 1986)
  • Treatment with antiretroviral agents can reverse
    CNS manifestations (Pizzo 1988, Brouwers 1990,
    McKinney 1991, Butler 1991, Tepper 1998, Mc Coig
    2002)
  • Access to HAART has dramatically decreased the
    incidence of active PHE to 1.6 (Chiraboga, 2005)

10
HIV and Neurodevelopment experience from the
US/Europe
  • Early and persistent delay in motor development
    distinguishes most strongly HIV infected from HIV
    exposed children (Epstein 1986, Chase 1995,
    Drotor 1999, Knight 2000)
  • Deceleration in mental development and delays in
    expressive speech occur in late infancy (Epstein
    1986, Moss 1996, McNeilly 1998, Davis-McFarland
    2000, Brouwers et al 1995)
  • Correlation between presence of PHE and outcome
    increased hospitalizations, lower CD4 count and
    short survival (Epstein 1986, Duliege 1992,
    Lobato, 1995)
  • Level of motor dysfunction and neuropsychological
    functioning provided predictive information
    beyond that obtainable from surrogate markers of
    HIV disease status (e.g. CD4 count, HIV RNA
    level). (Pearson et al. 2000)

11
HIV and Neurodevelopment experience from the
US/Europe
  • Broad variability in severity and timing, with
    the highest risk in the first year of life
    (Wachtel 1993, Epstein 1986, Lobato 1995,)
  • Highest risk occurs in the first and second year
    following HIV infection incidence rate of 10,
    4.25 and 1 in first, second and subsequent years
    of life. Compared to adults 0.3 in first year
    and 1 thereafter. The cumulative 7y incidence
    postinfection reached 16 in children vs 5 in
    adults (Tardieu 2000)

12
HIV and Neurodevelopment experience from Africa
  • Msellati et al, 1993, Rwanda (n20-43, age 0-24
    m)
  • Deliberately very simple screening tool
  • HIV infected children perform more poorly
    compared to HIV exposed infants
  • Boivin et al. 1995, Zaire (n11 -15 -15, age 3-18
    m)
  • Portions of the Early Childhood Screening
    Profiles (cognitive, language, motor) and Kaufman
    Assessment Battery for children (cognitive)
  • HIV infected children demonstrate global
    cognitive impairment that extends beyond the
    indirect effects of maternal illness
  • Spatial memory and motor functions were the most
    affected
  • A portion of the deficit may have been due to the
    effects of impaired health in the mother

13
HIV and Neurodevelopment experience from Africa
  • Drotar et al. 1997 and 1999, Uganda
    (n61-234-115, age 6-24m)
  • Bayley scales of Mental and Motor development,
    first edition, and Fagan test of intelligence
  • More frequent and earlier onset of deficits in
    motor than mental development
  • HIV infected children demonstrate a lower mental
    and motor development and a greater deceleration
    in their rate of motor development
  • Neurodevelopment is worse in children with
    abnormal neurological exam
  • No difference between HIV exposed uninfected and
    control children

14
Assessing neurodevelopmental outcome in African
children a challenge
  • Few neurodevelopmental assessment tools have been
    evaluated and validated outside of the US and
    Europe.
  • Capacity in neurodevelopmental assessment is
    extremely limited
  • How to disentangle the direct biological from the
    environmental and social impact of HIV on the
    neurodevelopment of HIV infected children in the
    sub-Saharan African context?

15
Neurodevelopmental concerns for orphans and other
vulnerable children
  • The illness of a parent marks the beginning of
    erosion of the family and trauma in the
    emotional, psychological and material life of a
    child
  • The HIV/AIDS epidemic is making millions of
    sub-Saharan African children vulnerable,
    including 12.3 million AIDS orphans (2003)
  • Neurodevelopmental consequences of being
    confronted with parents suffering from AIDS can
    erode the educational opportunities which are
    considered key components of a safety net for
    vulnerable children.

16
HIV/AIDS estimates for DRC and SA 2003
World Health Organization. Joint United Nations
Programme on HIV/AIDS. 2004 report on the global
HIV/AIDS epidemic 4th global report.
UNAIDS/04.16E.
17
Pilot Study Design
  • Prospective study
  • 35 HIV infected children at baseline, 6 and 12
    months post initiation of ART - Kinshasa
  • 35 HIV affected children (AIDS orphans and
    children of parents with symptomatic AIDS) -
    Kinshasa
  • 90 HIV unexposed healthy children with HIV
    negative mother and healthy parents (5 boys and
    5 girls for every 6 month age class between 18
    and 71 m) - Kinshasa and Cape Town
  • Data collection
  • Neurodevelopmental assessment
  • Maternal quality of life
  • Demographic parameters and family structure
  • clinical and immunological parameters

18
Selection of neurodevelopmental tools
  • Criteria for selection
  • Age specific tools
  • valid and reliable
  • Cross-cultural utility
  • Maximum of information in minimum of time
  • 18 months 30 months
  • Bayley (mental, motor and behavior)
  • Rossetti (language)
  • 30 months 72 months
  • SON-R 2.5-7 (mental)
  • Peabody (motor)
  • Rossetti (language)

19
Bayley Scales of Infant Development Second
Edition
  • Mental Scale and Motor Scale are for assessment
    of the current level of cognitive, language,
    personal-social, fine and gross motor development
  • Behavior Rating Scale assesses the childs
    behavior during testing
  • Used for children from 1 month to 36-42 months

20
Peabody Developmental Motor Scales
  • Reflexes, Stationary, Locomotion, Object
    Manipulation, Grasping, and Visual-Motor
    Integration
  • Results can be assessed as a total motor score or
    broken down to assess fine motor or gross motor
    capabilities separately
  • Used for children from birth through six years of
    age

21
Rossetti Infant-Toddler Language Scale
  • Assesses preverbal and verbal areas of
    communication and interaction
  • Uses direct observation, elicited behavior, or
    caregivers report to equally credit the childs
    performance, is therefore less dependant on the
    language itself, and is thus less problematic for
    use in different languages compared to other
    language scales
  • Six areas - Interaction-Attachment, Pragmatics,
    Gesture, Play, Language Comprehension, and
    Language Expression
  • Used in children from birth to 36 months
  • Problems
  • This measure has not been standardized, and there
    is no statistical information on it.
  • Gesture and play influenced by the general status
    (weakness)

22
Snijders-Oomen Nonverbal Intelligence Test
(SON-R) 2½-7
  • A nonverbal, language independent tool comprised
    of six subtests.
  • Two subtests (puzzles and analogies) were
    eliminated for the Africa version. The 4
    remaining tests are situations, mozaics,
    categories and patterns
  • Scores provide an overall IQ as well as a
    separate score for performance (P- IQ) and
    reasoning (R-IQ) subtests
  • Feedback is given after each item by telling the
    subject whether the solution was correct or
    incorrect, and an adaptive procedure is used to
    prevent the administration of too many easy or
    too many difficult questions
  • Appropriate for children from 2 and a half to
    seven years of age

23
Nonverbal Intelligence Test (SON-R) 2½-7
Challenges
  • Mosaic poor knowledge of colors
  • Categories and situations certain items are not
    recognized by the child and need modification for
    the African context
  • Many chose the ice-cream to feed the rabbit. Most
    children referred to the rabbit as a mouse. I got
    the impression that the children chose the
    ice-cream because it was something they would
    like to eat themselves
  • Suggestions

24
Preliminary results validity of assessment
tools in the Kinshasa context
  • Bayley motor scale
  • Bayley mental scale
  • Peabody motor scale
  • SON 2½-7

25
Bayley Scales of Infant Development, Psychomotor
Development Index (PDI)
26
Bayley Scales of Infant Development Mental
Development Index (MDI)
27
Peabody Developmental Motor Scales, Total Motor
Quotient (TMQ)
28
SON-R 2.5-7, SON-IQ mental
29
Conclusions validity of tools
  • Distribution of the scores for the control group
    is a normal distribution.
  • Mean and SD of the control group was not
    significantly different from the mean and SD of
    the normative populations.
  • There is a shift to the left for the mental
    development assessment tools, especially for the
    SON 2½-7. This may be improved by adapting some
    of the pictures to the sub-Saharan African
    context.

30
Preliminary results Comparison of motor and
mental development in HIV infected, HIV affected
and unaffected children
  • Bayley motor scale
  • Bayley mental scale
  • Peabody motor scale
  • SON 2½-7

31
Cross sectional data motor development children
aged 18-29 months
32
Cross sectional data mental development
children aged 18-29 months
33
Cross sectional data behavior of children aged
18-29 months
34
Cross sectional data motor development of
children aged 30-71 months
35
Cross sectional data motor development of
children aged 30-71 months
36
Cross sectional data language development
Language comprehension
Language expression
37
Cross sectional data motor and mental
development in children aged 18-29 months
38
Cross sectional data motor and mental
development in children aged 30-71 months
39
Conclusions Impact of HIV on neurodevelopment
  • Motor, mental and language development is delayed
    in a the overwhelming majority of HIV infected
    children.
  • HIV affected children had significant delays in
    their mental development, in both age groups. The
    motor development tended to be slower but the
    difference was borderline (18 -29 m) or not (30
    71 m) statistically significant.
  • The motor development of HIV infected children
    was significantly more pronounced than that of
    HIV affected children, possibly indicating both a
    biological and environmental component
  • The delay in mental development of young HIV
    infected children was more pronounced compared to
    that of young HIV affected children. This
    difference became non significant in the older
    age group, possibly indicating an important
    environmental factor in the older children.
  • Behavioral problems were identified in both HIV
    infected and affected children

40
Conclusions Impact of HIV on neurodevelopment
  • Impact seemed larger in the younger age group
  • Due to use of different tools in different age
    groups?
  • Younger children with neurodevelopmental problems
    are those infected in utero?
  • Due to effect of survival cohort?

41
Future directions CNS involvement in African
children in the era of increased access to ARV
  • Prospective study to address
  • incidence of CNS involvement
  • Effect of ARV
  • Scholastic achievement and special needs
  • Correlation between neurological delay and
    progression of HIV disease in the African
    context, and its implication for timing of
    initiation of ARV treatment
  • Sustainable care for neurodevelopmental
    challenged children infected and/or affected by
    HIV
Write a Comment
User Comments (0)
About PowerShow.com